We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.56%
2 Industrials 11.54%
3 Communication Services 11.47%
4 Financials 11.2%
5 Technology 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
76
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$42.2M 0.2%
238,718
-661,282
-73% -$106M
ZGNX
77
DELISTED
Zogenix, Inc.
ZGNX
$42M 0.2%
2,766,935
+516,935
+23% +$8.07M
ARNA
78
DELISTED
Arena Pharmaceuticals Inc
ARNA
$39.1M 0.18%
656,548
-193,452
-23% -$11.4M
AGIO icon
79
Agios Pharmaceuticals
AGIO
$1.93B
$37.8M 0.18%
818,767
-341,233
-29% -$16.5M
TVRD
80
Tvardi Therapeutics
TVRD
$23.4M
$30.9M 0.14%
55,556
– –
KVSC
81
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$27.5M 0.13%
2,809,000
– –
QTRX icon
82
Quanterix
QTRX
$190M
$27.1M 0.13%
545,000
– –
GPOR icon
83
Gulfport Energy Corp
GPOR
$2.88B
$26.5M 0.12%
322,119
-375,325
-54% -$26.1M
RGEN icon
84
Repligen
RGEN
$9.25B
$26.3M 0.12%
+91,070
New +$23.4M
RDUS
85
DELISTED
Radius Health, Inc.
RDUS
$26.2M 0.12%
2,107,400
– –
NEO icon
86
NeoGenomics
NEO
$2.13B
$25.6M 0.12%
529,839
+109,839
+26% +$5.08M
TRIL
87
DELISTED
Trillium Therapeutics Inc.
TRIL
$25.2M 0.12%
+1,435,000
New +$16.8M
MTAL.U
88
DELISTED
Metals Acquisition Corp Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
MTAL.U
$24.5M 0.11%
+2,475,000
New +$24.5M
AUS
89
DELISTED
Austerlitz Acquisition Corporation I
AUS
$24.4M 0.11%
2,456,887
+347,187
+16% +$3.44M
BACA.U
90
DELISTED
Berenson Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
BACA.U
$24.4M 0.11%
+2,475,000
New +$24.4M
IMA
91
ImageneBio Inc
IMA
$64.6M
$22.4M 0.1%
93,112
– –
NUVB icon
92
Nuvation Bio
NUVB
$2.32B
$22M 0.1%
2,210,000
-288,600
-12% -$2.62M
ANNX icon
93
Annexon
ANNX
$886M
$21.5M 0.1%
1,157,261
-200,846
-15% -$4.07M
DCRC
94
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
$20.1M 0.09%
2,000,000
– –
AZN icon
95
AstraZeneca
AZN
$250B
$20.1M 0.09%
+167,000
New +$19.4M
CVS icon
96
CVS Health
CVS
$122B
$19.9M 0.09%
+234,000
New +$19.6M
CLVR
97
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$19.7M 0.09%
84,792
– –
PSTH
98
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$19.7M 0.09%
+1,000,000
New +$20.3M
REVH
99
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$19.5M 0.09%
2,000,000
– –
NXDR
100
Nextdoor Holdings
NXDR
$986M
$19.4M 0.09%
1,900,787
-349,213
-16% -$3.59M
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Farallon Capital Management held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Farallon Capital Management withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Farallon Capital Management opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Farallon Capital Management's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Farallon Capital Management added most to Aramark in Q3 2021, an estimated $209M increase.
  • Farallon Capital Management's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Farallon Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Farallon Capital Management's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Farallon Capital Management opened 40 new positions and closed 34 in Q3 2021.
  • Farallon Capital Management's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.